Chemotherapy for Prostate Cancer

This publication has 10 references indexed in Scilit:

• Chemotherapy for prostatic carcinoma.
  1988
• Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide National prostatic cancer project randomized trial
  Urology, 1988
• Failure of chemotherapy to prolong life in patients with metastatic prostate cancer who have failed androgen deprivation
  Urology, 1988
• A Critical Assessment of the Role of Chemotherapy for Endocrine-Resistant Prostatic Carcinoma
  Urologic Clinics of North America, 1987
• Combined hormone-chemotherapy for metastatic prostatic carcinoma Eleven-year follow-up
  Urology, 1987
• Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?
  Journal of Clinical Oncology, 1985
• A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma.
  Journal of Clinical Oncology, 1985
• Treatment of advanced cancer of the prostate
  Seminars in Surgical Oncology, 1985
• Orchiectomy and chemotherapy with estramustine, cis-platinum, cyclophosphamide, and 5-fluorouracil in newly diagnosed prostate cancer with bone metastases
  Urology, 1984
• The Treatment of Oestrogen-Escaped Carcionoma of the Prostate with Estramustine Phosphate
  British Journal of Urology, 1977